Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Yang, Boyu [1 ]
Wu, Shaowen [1 ]
Yu, Shanshan [1 ]
Liang, Xiaoling [1 ]
Liu, Qifa [2 ]
Huang, Fen [2 ]
Liang, Lingyi [1 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangdong Prov Clin Res Ctr Ocular Dis,State Key, Guangdong Prov Key Lab Ophthalmol & Visual Sci, Guangzhou, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
BONE-MARROW-TRANSPLANTATION; VISUAL-EVOKED POTENTIALS; VERSUS-HOST-DISEASE; CYTOMEGALOVIRUS RETINITIS; OCULAR FINDINGS; SOLID-ORGAN; EYE;
D O I
10.1038/s41433-022-02250-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To study the posterior segment complications (PSC) and the risk factors in patients after allogeneic hematopoietic stem cell transplantation (HSCT). Methods This cross-sectional, case-control study enroled 143 patients who received allogeneic HSCT. Comprehensive ocular examinations were performed to evaluate PSC and ocular Graft-versus-Host Disease (oGVHD). PSC was diagnosed based on the characteristic fundus findings and auxiliary examinations. Visual-evoked potential was examined in patients with unexplained visual loss and suspected visual pathway pathology (VPP). Ocular surface disease index, corneal fluorescein staining, conjunctival injection and Schirmer's test were scored to diagnose oGVHD. Results PSC was detected in 36 (25.2%) patients, while 107 (74.8%) patients were not. Among them, 102 (71.3%) patients were diagnosed with oGVHD. The most common PSC included cytomegalovirus retinitis (13/143, 9.1%) and VPP (7/143, 4.9%). Central nervous system relapse of leukaemia was detected in four out of seven cases of VPP. Patients with PSC had worse visual acuity, lower prevalence and milder severity of oGVHD, and more donors from unrelated and human leucocyte antigen (HLA)-mismatch (all P < 0.05). PSC was associated with transplant from unrelated (OR = 6.494, 95% CI: 1.635-25.794, P = 0.008) and HLA-mismatched (OR = 7.193, 95% CI: 2.829-18.291, P < 0.001) donor but not with the occurrence of systemic GVHD or oGVHD. Conclusions PSC in post-HSCT patients was more common than previously noted, deserving the concern of ophthalmologists, especially in patients with unrelated or HLA-mismatched donors.
引用
收藏
页码:1816 / 1821
页数:6
相关论文
共 50 条
  • [31] Risk Factors for and the Prognostic Impact of Pericardial Effusion after Allogeneic Hematopoietic Stem Cell Transplantation
    Kubo, Hiroyuki
    Imataki, Osamu
    Fukumoto, Tetsuya
    Oku, Maki
    Ishida, Tomoya
    Kubo, Yukiko Hamasaki
    Kida, Jun-ichiro
    Uemura, Makiko
    Fujita, Haruyuki
    Ohno, Hirofumi
    Ide, Makoto
    Ohnishi, Hiroaki
    Kadowaki, Norimitsu
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 949.e1 - 949.e8
  • [32] Risk Factors for Readmission after Allogeneic Hematopoietic Stem Cell Transplantation and Impact on Overall Survival
    Spring, Laura
    Li, Shuli
    Soiffer, Robert J.
    Antin, Joseph H.
    Alyea, Edwin P., III
    Glotzbecker, Brett
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) : 509 - 516
  • [33] Prevalence, Risk Factors, and Outcomes of Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Bertelli, Luca
    Cazzato, Salvatore
    Belotti, Tamara
    Prete, Arcangelo
    Ricci, Giampaolo
    Pession, Andrea
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2017, 30 (02) : 113 - 115
  • [34] PREVALENCE, RISK FACTORS AND OUTCOMES OF BRONCHIOLITIS OBLITERANS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Bertelli, L.
    Martoni, A.
    Bardasi, G.
    Massaccesi, E.
    Zama, D.
    Morello, W.
    Cazzato, S.
    Masetti, R.
    Rondelli, R.
    Prete, A.
    Pession, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S258 - S258
  • [35] Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
    Uderzo, Cornelio
    Bonanomi, Sonia
    Busca, Alessandro
    Renoldi, Mila
    Ferrari, Pierantonio
    Iacobelli, Massimo
    Morreale, Giuseppe
    Lanino, Edoardo
    Annaloro, Claudio
    Della Volpe, Aldo
    Alessandrino, Paolo
    Longoni, Daniela
    Locatelli, Franco
    Sangalli, Haidi
    Rovelli, Attilio
    TRANSPLANTATION, 2006, 82 (05) : 638 - 644
  • [36] Complications of the posterior eye segment after allogeneic hematopoietic cell transplantation and identification of T cell epitopes as neo-autoimmune targets
    Simon, C.
    Mirza, N.
    Zierhut, M.
    Korn, A.
    Bornemann, A.
    Wirths, S.
    Boehm, A.
    Bethge, W. A.
    Kanz, L.
    Rammensee, H. -G
    Haen, S. P.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 40 - 40
  • [37] Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation
    A Bjorklund
    J Aschan
    M Labopin
    M Remberger
    O Ringden
    J Winiarski
    P Ljungman
    Bone Marrow Transplantation, 2007, 40 : 1055 - 1062
  • [38] Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation
    Bjorklund, A.
    Aschan, J.
    Labopin, M.
    Remberger, M.
    Ringden, O.
    Winiarski, J.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2007, 40 (11) : 1055 - 1062
  • [39] Risk Factors and Prognostic Markers for Posterior Reversible Encephalopathy Syndrome in Patients With Thalassemia Major After Allogeneic Hematopoietic Stem Cell Transplantation
    Bu, Meiru
    Deng, Kemei
    Wu, Meiqing
    Shi, Lingling
    Qin, Yuhong
    Jiang, Muliang
    Chen, Bihong T.
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (03) : 520 - 522
  • [40] Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
    Landgren, Ola
    Gilbert, Ethel S.
    Rizzo, J. Douglas
    Socie, Gerard
    Banks, Peter M.
    Sobocinski, Kathleen A.
    Horowitz, Mary M.
    Jaffe, Elaine S.
    Kingma, Douglas W.
    Travis, Lois B.
    Flowers, Mary E.
    Martin, Paul J.
    Deeg, H. Joachim
    Curtis, Rochelle E.
    BLOOD, 2009, 113 (20) : 4992 - 5001